Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Clinical trial NCT04892849 · RECRUITING

Trial details

NCT number: NCT04892849
Sponsor: University of Erlangen-Nürnberg Medical School
Status: RECRUITING
Study type: OBSERVATIONAL

HNSCC NSCLC Esophageal Cancer Urothelial Carcinoma Renal Cell Carcinoma Squamous Cell Carcinoma of the Skin Small Cell Bronchial Carcinomas

Start date: 2021-04-30
Primary completion: 2028-05-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.